Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

AARTI PHARMALABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 21.3713.5264.41--

What is the latest Core EBITDA Growth ratio of AARTI PHARMALABS ?

The latest Core EBITDA Growth ratio of AARTI PHARMALABS is 21.37 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202521.37
Mar202413.52
Mar202364.41
Mar2022-
Mar2021-

How is Core EBITDA Growth of AARTI PHARMALABS Trending?

Years Core EBITDA Growth % Change
Mar2025 21.37
58.06
Mar2024 13.52
-79.01
Mar2023 64.41
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Growth ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹7,093.5 Cr 6.4% 7.4% 31% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 7.1% -1.5% -6.2% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 2.8% -2.8% 6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 3.1% 4.2% 18.8% Stock Analytics
CIPLA ₹107,075.0 Cr 0.2% -12.5% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 2.2% -1.6% 0% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

6.4%

7.4%

31%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses